ACTINIUM PHARMACEUTICALS, INC. Liabilities Assumed
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Liabilities Assumed of -$10.69 thousand for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2011-11-14
- ACTINIUM PHARMACEUTICALS, INC. liabilities assumed for the quarter ending 2011-09-30 was $0.00.
- ACTINIUM PHARMACEUTICALS, INC. liabilities assumed for the quarter ending 2010-09-30 was $0.00.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 6 month | Liabilities Assumed 9 month |
|---|---|---|---|
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$10.69K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$10.69K 10-Q · filed 2011-08-12 | ||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $0.00 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |